Monday, November 13, 2023
- 9:00AM-11:00AM
-
Abstract Number: 1266
The Anti-inflammatory Effect of High-density Lipoprotein Is Blunted by Delivery of Altered MicroRNA Cargo to Macrophages in Patients with Rheumatoid Arthritis
(1264–1307) RA – Diagnosis, Manifestations, and Outcomes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1222
The Association Between Gingival Inflammation and Clinical Signs of Active Juvenile Dermatomyositis (JDM)
(1221–1255) Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease- 9:00AM-11:00AM
-
Abstract Number: 1401
The Association of 3VAS/4VAS and DAPSA with Radiographic Progression in Early PsA
(1383–1411) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II: Imaging & AS- 9:00AM-11:00AM
-
Abstract Number: 1543
The Association of Frailty with Outcomes in Patients with Vasculitis
(1534–1553) Vasculitis – ANCA-Associated Poster II: Epidemiology, Outcomes, & Classification- 9:00AM-11:00AM
-
Abstract Number: 1193
The Association of Peak Forces and Loading Rates During Walking with MRI-Based Structural Worsening of the Knee: The Multicenter Osteoarthritis Study
(1183–1199) Osteoarthritis – Clinical Poster II- 9:00AM-11:00AM
-
Abstract Number: 1237
The Associations Between Depressive Symptoms and Executive Function and Academic Outcomes in Children with SLE
(1221–1255) Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease- 9:00AM-11:00AM
-
Abstract Number: 1542
The Burden of Multimorbidity in ANCA-Associated Vasculitis: A Cohort Study
(1534–1553) Vasculitis – ANCA-Associated Poster II: Epidemiology, Outcomes, & Classification- 9:00AM-11:00AM
-
Abstract Number: 0966
The Burden of Oligoarticular Psoriatic Arthritis in the United States
(0965–0992) Epidemiology & Public Health Poster II- 9:00AM-11:00AM
-
Abstract Number: 0894
The Cellular and Spatial Type I Interferon Response Following Skin Exposure to Ultraviolet Light
(0886–0898) SLE – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 1116
The Current State of Sodium-Glucose Cotransporter Type 2 Inhibitor Use Among Patients with Gout at a Tertiary Academic Healthcare System
(1100–1123) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster II- 9:00AM-11:00AM
-
Abstract Number: 1342
The Delivery of the Super-repressor IκBα by Exosomes Has the Potential to Alleviate Inflammation Associated with Rheumatoid Arthritis
(1308–1344) RA – Treatments Poster II- 9:00AM-11:00AM
-
Abstract Number: 1033
The Detection of Subclinical Joint Inflammation by Thermal and Ultrasound Imaging at the Metacarpophalangeal Joints in Patients with Rheumatoid Arthritis
(1033–1051) Imaging of Rheumatic Diseases Poster I- 9:00AM-11:00AM
-
Abstract Number: 1494
The Effect of Belimumab on Steroid Use in Patients with SLE: Results from a Retrospective Observational Study of Real-World Data from a US Rheumatology Provider Network
(1488–1512) SLE – Treatment Poster II